Month: February 2022

Northwestern Medicine investigators have discovered a novel mechanism that connects circadian rhythm-controlled cellular metabolism and regeneration with muscle repair after injury.

Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.

A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.

The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.

Idiopathic dilated cardiomyopathy (DCM) was found to have a familial etiology in 30 percent of individuals diagnosed with DCM, and the overall risk for a family member of developing DCM was nearly 20 percent by the age of 80.

Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.

Pregnant and postpartum individuals infected with SARS-CoV-2 during pregnancy have an increased risk of maternal mortality or morbidity from obstetric complications, according to a recent study.

A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.

Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment. 

Treating breast tumors alongside distant metastases did not improve outcomes in women with stage IV breast cancer, according to a new study.